This site is reserved exclusively for licensed dental professionals.
Free shipping within Italy on orders of at least €150.00 i.e.
Aliquota IVA applicata: 22%
NanoBone® Granular 2.4 ml Artoss is a synthetic material for bone reconstruction in dentistry, consisting of nanocrystalline hydroxyapatite incorporated in a silica gel.

With the synthetic material NanoBone® the dentist is offered a safe material for bone reconstructions. After more than 5 years of use in office settings with over 100,000 treatments worldwide, NanoBone® has proven all its qualities. Users can choose from a variety of products for specific indications. The NanoBone® synthetic reconstruction material is available in granular or block form. An entire technology – the NanoBone® technology – offers a wide range of products, which simplify daily work in the dental office. Long-term studies confirm all the good reasons to choose NanoBone®.
NanoBone® in granular form is available, for daily surgical use, according to the indication and the size of the defect, in very small granules (0.6 x 2 mm) or small granules (1 x 2 mm). In order to treat the various indications with specific products, the NanoBone® technology makes available granules with differentiated resorption kinetics. NanoBone® in granular form is the first product of the NanoBone® technology and was launched on the market in 2005. The product description highlights its ease of use. By mixing it with the patient's blood, a paste-like consistency is obtained that can be easily inserted, with appropriate instruments, where needed.
All products of the NanoBone® technology are produced using the sol-gel method at 700° C. Thanks to this low temperature, the material is not sintered, presenting a highly porous surface with pores ranging from nanometers to micrometers. The autologous blood proteins penetrate into these nanopores, coating their entire inner surface. Our body recognizes NanoBone® as an endogenous element and this triggers the natural remodeling process.
Harms et al. attribute a high osteoconductive potential to NanoBone®. The augmentation material acts as a guardrail. With the formation of a protein-rich organic matrix, the internal growth of connective tissue and blood vessels is promoted.
Götz et al. have demonstrated the osteoinductive nature of NanoBone®. It could be demonstrated an attraction and differentiation of osteoblasts and osteoclasts. In animal experiments with Gottinga piglet, ectopic bone formation was observed.
In addition to the bone replacement materials previously available on the market, the NanoBone® technology represents a completely new group. Nanocrystalline hydroxyapatite (HA) is incorporated in a silica gel (SiO2). This nanocrystalline hydroxyapatite corresponds approximately to that present in autologous bone. The silica gel promotes the formation of collagen and bone.
With production according to the sol-gel method at temperatures up to 700° C, the material is not sintered and presents pores ranging from nanometers to micrometers. The potential of nanotechnology is exploited with HA nanocrystals and interconnected nanopores. The blood proteins coat the entire inner surface (ca. 84 m²/g) and the body recognizes the biomaterial almost as an endogenous element.
Within the first two weeks, the silica gel matrix transforms into an organic matrix. Through this process, every granule of NanoBone® now corresponds to the extracellular matrix of bone tissue.
NanoBone® promotes natural remodeling. The attraction and differentiation of osteoblasts and osteoclasts strongly suggest an osteoinductive biomaterial character.
